Biodefense market seen reaching $30.05B by 2030

The Business Research Company says the biodefense market is set to grow from $20.23 billion in 2025 to $22.07 billion in 2026, then hit $30.05 billion by 2030. The forecast points to rising demand for detection tools, vaccines and emergency response systems as governments respond to biological threats and infectious disease risks.

Why it matters: - The biodefense market is expanding as governments and health systems invest more in tools to detect, prevent and respond to biological threats. - The forecast suggests sustained demand for vaccines, surveillance systems and rapid-response infrastructure through 2030. - Emerging infectious diseases remain a major driver of spending and preparedness.

What happened: - The Business Research Company released a new biodefense market analysis on Nov. 5, 2026. - The report estimates the global biodefense market will rise from $20.23 billion in 2025 to $22.07 billion in 2026. - The report projects the market will reach $30.05 billion by 2030. - The forecast implies a 9.1% compound annual growth rate in 2026 and an 8.0% CAGR over the broader period to 2030. - North America held the largest share of the global biodefense market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the biodefense market report. - View the full biodefense market report.

The details: - The report says biodefense covers strategies and protective measures against biological hazards, including the intentional release of harmful pathogens or biotoxins. - The market includes detection systems, vaccines, treatments and emergency preparedness planning. - The report identifies heightened government funding, concerns over global health security, national reserve expansion, vaccine research advances and stronger biosurveillance as major historical growth drivers. - The report cites rising geopolitical instability, broader disease monitoring networks, investment in innovative vaccines, AI-powered threat analytics and rapid-response systems as growth drivers through 2030. - The report highlights swift biothreat detection, advanced medical countermeasures, pandemic preparedness infrastructure, integrated emergency response platforms and improved biothreat surveillance as key trends. - The World Health Organization said in July 2024 that it responded to 72 health emergencies in 2023, including 19 high-priority grade-3 outbreaks. - That WHO data underscores continuing infectious disease pressure that feeds demand for biodefense capabilities. - The Business Research Company said its 2026 market reports include market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and future trend analysis.

Between the lines: - The forecast points to biodefense becoming a more persistent budgeting priority, not just a crisis-driven category. - The emphasis on AI analytics, monitoring networks and rapid-response systems suggests the market is shifting from point solutions toward integrated preparedness platforms. - North America’s current lead and Asia-Pacific’s growth outlook indicate a market that is both mature in established defense spending and expanding where governments are scaling health security capacity.

What's next: - Biodefense demand is likely to track future outbreaks, geopolitical tensions and public-health preparedness spending. - The report’s projected growth suggests more room for vendors focused on vaccines, surveillance, detection and emergency response technologies. - Governments and health agencies are expected to keep investing in faster detection and broader preparedness systems as biological risks evolve.